Clinical trial
Lung Health Study II
NCT00000569 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00000569 |
|---|---|
| Title | Lung Health Study II |
| Official title | The Chronic Obstructive Pulmonary Disease Early Intervention Trial |
| Acronym | LHSII |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Diseases, Obstructive, Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug, Other |
| Interventions | triamcinolone, Placebo |
| Enrollment | 1,116 |
| Start date | Sep 1, 1993 |
| Primary completion | May 1, 1999 |
| Completion | May 1, 1999 |
| First posted | Oct 28, 1999 |
| Last update posted | Nov 1, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: